Abbott Labs To Pay $700M In Depakote Criminal Case

Law360, New York (October 2, 2012, 8:15 PM EDT) -- A Virginia federal judge on Tuesday ordered Abbott Laboratories to hand over $700 million for criminal misconduct as part of a $1.6 billion settlement it inked earlier this year over off-label marketing, kickbacks and false claims related to anti-seizure drug Depakote.

As a result of Abbott’s guilty plea on a misdemeanor count of misbranding, U.S. District Judge Samuel G. Wilson fined the drugmaker $500 million, the second-largest such penalty on record for conduct involving a single drug, and directed it to forfeit about $200 million. That...
To view the full article, register now.